| Metric | Q3 2025 | Q2 2025 | Q3 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $240M | $168M | — | 43.0% | — |
| Op. Income | $36M | $4M | — | 716.2% | — |
| Gross Margin | 42.0% | 45.6% | — | -3.6pp | — |
| Net Margin | 0.5% | -5.1% | — | 5.6pp | — |
| EPS (Diluted) | $-0.00 | $-0.18 | — | 99.5% | — |
| Free Cash Flow | $12M | $13M | — | -11.6% | — |
| Item | Amount |
|---|---|
| REVENUE | $240M |
| Cost of Revenue | $139M |
| GROSS PROFIT | $101M |
| R&D Expenses | $0 |
| Selling & Marketing | $30M |
| General & Administrative | $35M |
| SG&A Expenses | $65M |
| Other Expenses | $0 |
| Operating Expenses | $65M |
| Cost & Expenses | $204M |
| OPERATING INCOME | $36M |
| Interest Income | $0 |
| Interest Expense | $11M |
| Other Income/Expenses | -$34M |
| INCOME BEFORE TAX | $2M |
| Income Tax Expense | -$3M |
| Net Income from Continuing Ops | $5M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $1M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | -$49.0K |
| D&A | $15M |
| EBIT | $13M |
| EBITDA | $29M |
| EPS | -$0 |
| EPS Diluted | -$0 |
| Item | Amount |
|---|---|
| REVENUE | $240M |
| Cost of Revenue | $139M |
| GROSS PROFIT | $101M |
| R&D Expenses | $0 |
| Selling & Marketing | $30M |
| General & Administrative | $35M |
| SG&A Expenses | $65M |
| Other Expenses | $0 |
| Operating Expenses | $65M |
| Cost & Expenses | $204M |
| OPERATING INCOME | $36M |
| Interest Income | $0 |
| Interest Expense | $11M |
| Other Income/Expenses | -$34M |
| INCOME BEFORE TAX | $2M |
| Income Tax Expense | -$3M |
| Net Income from Continuing Ops | $5M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $1M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | -$49.0K |
| D&A | $15M |
| EBIT | $13M |
| EBITDA | $29M |
| EPS | -$0 |
| EPS Diluted | -$0 |
| Item | Amount |
|---|---|
| Net Income | $1M |
| Depreciation & Amortization | $23M |
| Stock-Based Compensation | $5M |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$12M |
| Change in Working Capital | $2M |
| OPERATING CASH FLOW | $20M |
| Capital Expenditure | -$8M |
| Acquisitions (Net) | -$2M |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | -$9M |
| Net Debt Issuance | -$635M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | $668M |
| NET CASH FROM FINANCING | $33M |
| FREE CASH FLOW | $12M |
| Net Change in Cash | $43M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $262M |
| Short-Term Investments | $0 |
| Net Receivables | $0 |
| Inventory | $0 |
| Other Current Assets | $68M |
| TOTAL CURRENT ASSETS | $364M |
| PP&E (Net) | $528M |
| Goodwill | $61M |
| Intangible Assets | $17M |
| Long-Term Investments | $0 |
| Tax Assets | $0 |
| Other Non-Current Assets | $7M |
| TOTAL NON-CURRENT ASSETS | $613M |
| TOTAL ASSETS | $977M |
| Account Payables | $21M |
| Short-Term Debt | $10.0K |
| Deferred Revenue | $0 |
| Other Current Liabilities | $362M |
| TOTAL CURRENT LIABILITIES | $439M |
| Long-Term Debt | $663M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $3M |
| TOTAL NON-CURRENT LIABILITIES | $667M |
| TOTAL LIABILITIES | $1.1B |
| Common Stock | $6.0K |
| Additional Paid-In Capital | $128M |
| Retained Earnings | -$385M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $0 |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | -$175M |
| Minority Interest | $46M |
| TOTAL EQUITY | -$129M |
| TOTAL LIABILITIES & EQUITY | $977M |
| Total Debt | $665M |
| Net Debt | $403M |
